Free Trial

Cronos Group (NASDAQ:CRON) Trading Up 0.5% - Still a Buy?

Cronos Group logo with Medical background

Cronos Group Inc. (NASDAQ:CRON - Get Free Report)'s stock price was up 0.5% on Monday . The stock traded as high as $1.92 and last traded at $1.91. Approximately 844,381 shares changed hands during trading, a decline of 37% from the average daily volume of 1,338,835 shares. The stock had previously closed at $1.90.

Cronos Group Stock Performance

The firm has a 50 day moving average of $1.94 and a two-hundred day moving average of $1.92. The stock has a market cap of $736.65 million, a P/E ratio of 14.69, a P/E/G ratio of 32.31 and a beta of 1.04.

Cronos Group (NASDAQ:CRON - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.01. Cronos Group had a negative return on equity of 0.07% and a net margin of 39.69%. The firm had revenue of $33.62 million during the quarter, compared to the consensus estimate of $45.44 million. On average, sell-side analysts anticipate that Cronos Group Inc. will post -0.03 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Dimensional Fund Advisors LP lifted its position in shares of Cronos Group by 5.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,753,055 shares of the company's stock worth $5,561,000 after acquiring an additional 132,536 shares during the period. MMCAP International Inc. SPC lifted its position in shares of Cronos Group by 2.9% in the 1st quarter. MMCAP International Inc. SPC now owns 1,786,382 shares of the company's stock worth $3,233,000 after acquiring an additional 49,782 shares during the period. Cannell Capital LLC bought a new stake in shares of Cronos Group in the 4th quarter worth approximately $3,323,000. Goldman Sachs Group Inc. lifted its position in shares of Cronos Group by 84.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,076,405 shares of the company's stock worth $1,948,000 after acquiring an additional 493,161 shares during the period. Finally, Millennium Management LLC lifted its position in shares of Cronos Group by 23.7% in the 4th quarter. Millennium Management LLC now owns 840,374 shares of the company's stock worth $1,698,000 after acquiring an additional 161,163 shares during the period. Institutional investors own 8.71% of the company's stock.

Cronos Group Company Profile

(Get Free Report)

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cronos Group Right Now?

Before you consider Cronos Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.

While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Defense Stocks Under $10 With Massive Upside
NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines